These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


307 related items for PubMed ID: 10874665

  • 1. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations.
    Günther T, Schneider-Stock R, Häckel C, Kasper HU, Pross M, Hackelsberger A, Lippert H, Roessner A.
    Mod Pathol; 2000 Jun; 13(6):621-6. PubMed ID: 10874665
    [Abstract] [Full Text] [Related]

  • 2. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H, Matthay K, Schmitt B, Bauknecht T, Kiechle-Schwarz M, Göppinger A, Pfleiderer A.
    Cancer; 1995 Jul 01; 76(1):57-66. PubMed ID: 8630877
    [Abstract] [Full Text] [Related]

  • 3. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
    Günther T, Schneider-Stock R, Rys J, Niezabitowski A, Roessner A.
    J Cancer Res Clin Oncol; 1997 Jul 01; 123(7):388-94. PubMed ID: 9260591
    [Abstract] [Full Text] [Related]

  • 4. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis.
    Blok P, Craanen ME, Dekker W, Offerhaus GJ, Tytgat GN.
    J Pathol; 1998 Sep 01; 186(1):36-40. PubMed ID: 9875138
    [Abstract] [Full Text] [Related]

  • 5. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma.
    Mori S, Ito G, Usami N, Yoshioka H, Ueda Y, Kodama Y, Takahashi M, Fong KM, Shimokata K, Sekido Y.
    Cancer; 2004 Apr 15; 100(8):1673-82. PubMed ID: 15073856
    [Abstract] [Full Text] [Related]

  • 6. P53-protein accumulation and MDM2-protein overexpression in gastric carcinomas. No apparent correlation with survival.
    Kasper HU, Schneider-Stock R, Mellin W, Günther T, Roessner A.
    Pathol Res Pract; 1999 Apr 15; 195(12):815-20. PubMed ID: 10631716
    [Abstract] [Full Text] [Related]

  • 7. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2000 Sep 15; 13(9):994-1004. PubMed ID: 11007040
    [Abstract] [Full Text] [Related]

  • 8. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.
    Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708
    [Abstract] [Full Text] [Related]

  • 9. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME, Blok P, Offerhaus GJ, Meijer GA, Dekker W, Kuipers EJ, Meuwissen SG.
    J Pathol; 1999 Dec 15; 189(4):481-6. PubMed ID: 10629547
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P, Bartkowiak JK, Szadowska AM, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    J Exp Clin Cancer Res; 1999 Sep 15; 18(3):403-16. PubMed ID: 10606188
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma.
    Jablkowski M, Bocian A, Bialkowska J, Bartkowiak J.
    J Exp Clin Cancer Res; 2005 Mar 15; 24(1):117-25. PubMed ID: 15943041
    [Abstract] [Full Text] [Related]

  • 12. Abnormal expression of MDM2 in prostate carcinoma.
    Leite KR, Franco MF, Srougi M, Nesrallah LJ, Nesrallah A, Bevilacqua RG, Darini E, Carvalho CM, Meirelles MI, Santana I, Camara-Lopes LH.
    Mod Pathol; 2001 May 15; 14(5):428-36. PubMed ID: 11353053
    [Abstract] [Full Text] [Related]

  • 13. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I, Tanaka H, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K.
    Clin Cancer Res; 1995 Jul 15; 1(7):769-73. PubMed ID: 9816044
    [Abstract] [Full Text] [Related]

  • 14. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
    Shwe M, Chiguchi G, Yamada S, Nakajima T, Maung KK, Takagi M, Amagasa T, Tsuchida N.
    J Med Dent Sci; 2001 Dec 15; 48(4):113-9. PubMed ID: 12160248
    [Abstract] [Full Text] [Related]

  • 15. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
    Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C.
    Am J Pathol; 1998 Dec 15; 153(6):1749-65. PubMed ID: 9846966
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA, Zekri AR, Abdallah S, El-Shehaby AM, Sherif GM.
    Pathol Int; 2005 Feb 15; 55(2):53-62. PubMed ID: 15693850
    [Abstract] [Full Text] [Related]

  • 17. Role of P53 and MDM2 in treatment response of human germ cell tumors.
    Kersemaekers AM, Mayer F, Molier M, van Weeren PC, Oosterhuis JW, Bokemeyer C, Looijenga LH.
    J Clin Oncol; 2002 Mar 15; 20(6):1551-61. PubMed ID: 11896104
    [Abstract] [Full Text] [Related]

  • 18. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.
    Yamamoto H, Oda Y, Saito T, Sakamoto A, Miyajima K, Tamiya S, Tsuneyoshi M.
    Histopathology; 2003 May 15; 42(5):431-9. PubMed ID: 12713619
    [Abstract] [Full Text] [Related]

  • 19. Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.
    Ittmann M, Wieczorek R, Heller P, Dave A, Provet J, Krolewski J.
    Am J Pathol; 1994 Aug 15; 145(2):287-93. PubMed ID: 8053489
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA, Middleton SK, Picksley SM, Hahn FF, Nikula KJ.
    Radiat Res; 1996 Apr 15; 145(4):449-56. PubMed ID: 8600505
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.